Skip to content
    Drishti.money
    Earnings calls

    Blue Jet Health concall ledger

    Every earnings call for BLUEJET — management tone, guidance, KPIs and promise tracking, quarter by quarter.

    BLUEJET · 7 transcripts · Healthcare · latest Q4 FY26
    Q3 FY26Published 13 Feb 2026Call held 13 Feb 2026

    BLUEJET Q3 FY26 Earnings Call Transcript & Analysis

    Revenue from Operations₹192.4 cr−40% YoYEBITDA Margin24%−62% YoYGross Margin52%

    Revenue from Operations ₹192 cr (−40% YoY); EBITDA Margin 24.0% (−62% YoY); Gross Margin (Q3) 52.0%. Vizag Greenfield project groundbreaking scheduled for this month, with Rs.1,000 crores investment over 3-4 years.

    Read full transcript & analysis
    Q2 FY26Published 04 Nov 2025Call held 04 Nov 2025

    BLUEJET Q2 FY26 Earnings Call Transcript & Analysis

    Revenue₹165 cr−21% YoYEBITDA₹60.1 cr+14% YoYEBITDA Margin36%PAT₹43.2 crPAT Margin26%

    Revenue (Q2) ₹165 cr (−21% YoY); EBITDA (Q2) ₹60 cr (+14% YoY); EBITDA Margin (Q2) 36%. Q2 FY26 Revenue from operations (excl. other income) was ₹165 crores, a decrease of 54% QoQ and 21% YoY.

    Read full transcript & analysis
    Q4 FY25Published 22 Jul 2025Call held 22 Jul 2025

    BLUEJET Q4 FY25 Earnings Call Transcript & Analysis

    Revenue3,548 million+118% YoYEBITDA1,210 million+178% YoYEBITDA Margin34%PAT912 million+114% YoYGross Margin48.5%

    Revenue 3548 million (+118% YoY); EBITDA 1210 million (+178% YoY); EBITDA Margin 34%. Revenue from operations at ₹354.8 crores, up 4% sequentially and 118% year-on-year.

    Read full transcript & analysis
    Q3 FY25Published 29 Jan 2025Call held 29 Jan 2025

    BLUEJET Q3 FY25 Earnings Call Transcript & Analysis

    Revenue3,184 million+91% YoYEBITDA1,240 million+127% YoYEBITDA Margin39%PAT990 million+208% YoYPAT Margin28.3%

    Revenue (Q3 FY25) 3184 million (+91% YoY); EBITDA (Q3 FY25) 1240 million (+127% YoY); EBITDA Margin (Q3 FY25) 39.0%. Q3 FY25 Revenue reached INR3,184 million, up 53% QoQ and 91% YoY.

    Read full transcript & analysis